This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Cenyx Biotech Inc., Seoul National University. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: The Innovative Contributions of Han-Gil Jeong
Introduction
Han-Gil Jeong is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biomedical treatment through his innovative research and development. With a total of 4 patents, Jeong is recognized for his work in creating advanced materials for medical applications.
Latest Patents
Jeong's latest patents include a ceria nanocomposite for biomedical treatment and a pharmaceutical composition containing the same. The first patent discloses a ceria nanocomposite that includes a ceria nanoparticle and a surface modification layer. This layer is composed of a polyethylene glycol residue, and the ceria nanoparticle has a higher content of Ce than Ce. The second patent focuses on a ceria nanocomposite specifically designed for treating subarachnoid hemorrhage. It also includes a method for preparing the ceria nanoparticle and a pharmaceutical composition that incorporates this innovative material.
Career Highlights
Han-Gil Jeong is currently associated with Cenyx Biotech Inc., where he continues to push the boundaries of biomedical research. His work has garnered attention for its potential to improve treatment outcomes in various medical conditions.
Collaborations
Jeong collaborates with notable colleagues, including Bong Geun Cha and Jaeyun Kim, who contribute to his research endeavors. Their combined expertise enhances the innovative capacity of their projects.
Conclusion
Han-Gil Jeong's contributions to the field of biomedical treatment through his patents and collaborations highlight his role as a leading inventor. His work promises to advance medical science and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
